Hydrogel is defined as a network of water-insoluble polymer chains that are utilized in the form of a gel in the healthcare and agriculture industries. It contains highly absorbent natural or synthetic polymers, and it has a hydrophilic structure. The hydrogel market is estimated to be USD 11.43 billion in 2017 and is projected to reach USD 15.33 billion by 2022, at a CAGR of 6.04% from 2017 to 2022. The rising demand for hydrogels in wound care application and increasing popularity of hydrogel contact lens are factors anticipated to drive the growth of the hydrogel market.
Asia Pacific accounted for the largest share of the hydrogel market in 2016. This market in the Asia Pacific region is projected to grow at the highest CAGR from 2017 to 2022. Among all countries in the Asia Pacific region, the hydrogel market in India is projected to grow at the highest CAGR during the forecast period. This market in North America is projected to grow at the second-highest CAGR between 2017 and 2022, with the US registering the highest growth rate in this region.
The hydrogel market is led by major players in the healthcare and chemicals industries. Johnson & Johnson (US), Cardinal Health (US), The 3M Company (US), Coloplast (Denmark), B. Braun Melsungen (Germany), Smith & Nephew (UK), Derma Sciences (US), Royal DSM (Netherlands), Dow Corning Corporation (US), Paul Hartmann (Germany), Momentive Performance Materials (US), Ocular Therapeutix (US), ConvaTec (UK), Ashland (US), Evonik Industries (Germany), Cosmo Bio USA (US), MPM Medical (US), Molnlycke Health Care (Sweden), Hollister (US), Medline Industries (US), Gentell (US), and Alliqua Biomedical (US) are key players operating in the hydrogel market. These players have adopted various growth strategies to expand their global presence and increase their market share. Mergers & acquisitions, expansions, and new product launches are some of the major strategies adopted by leading players operating in the hydrogel market.
